Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS – NO

W. Oliver Tobin, Brian G. Weinshenker

Research output: Contribution to journalArticlepeer-review

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)1190-1192
Number of pages3
JournalMultiple Sclerosis
Issue number9
StatePublished - Aug 1 2017

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this